(Q46194107)

English

Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

pulmonary hypertension

1 reference

based on heuristic

inferred from title

author name string

Alisa Limsuwan

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Anan Khosithseth

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Suthep Wanichkul

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Pongsak Khowsathit

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Catheterization and Cardiovascular Interventions

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

73

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

98-104

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Pulmonary vascular disease with congenital heart lesions: pathologic features and causes

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Inhaled nitric oxide in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Effect of breathing oxygen on pulmonary artery pressure and pulmonary vascular resistance in patients with ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCCD.21793

21 January 2018

Identifiers

10.1002/CCD.21793

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19089967

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46194107&oldid=2099211020"